Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Centro Bioindustrial | pt_BR |
dc.contributor.author | Lobato, Tiago Bertola | pt_BR |
dc.contributor.author | Gennari-Felipe, Matheus | pt_BR |
dc.contributor.author | Pauferro, Janaína Ribeiro Barbosa | pt_BR |
dc.contributor.author | Curi, Rui | pt_BR |
dc.date.accessioned | 2022-11-25T14:27:57Z | - |
dc.date.available | 2022-11-25T14:27:57Z | - |
dc.date.issued | 2022 | pt_BR |
dc.identifier.citation | Lobato TB, Gennari-Felipe M, Pauferro JRB, Curi R. Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity. Front Microbiol. . doi:10.3389/fmicb.2022.1037469. | pt_BR |
dc.identifier.uri | https://repositorio.butantan.gov.br/handle/butantan/4700 | - |
dc.description.abstract | Recent studies show that the metabolic characteristics of different leukocytes, such as, lymphocytes, neutrophils, and macrophages, undergo changes both in the face of infection with SARS-CoV-2 and in obesity and type 2 diabetes mellitus (DM2) condition. Thus, the objective of this review is to establish a correlation between the metabolic changes caused in leukocytes in DM2 and obesity that may favor a worse prognosis during SARS-Cov-2 infection. Chronic inflammation and hyperglycemia, specific and usual characteristics of obesity and DM2, contributes for the SARS-CoV-2 replication and metabolic disturbances in different leukocytes, favoring the proinflammatory response of these cells. Thus, obesity and DM2 are important risk factors for proinflammatory response and metabolic dysregulation that can favor the occurrence of the cytokine storm, implicated in the severity and high mortality risk of the COVID-19 in these patients. | pt_BR |
dc.description.sponsorship | (FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo | pt_BR |
dc.description.sponsorship | (CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | pt_BR |
dc.description.sponsorship | (CNPq) Conselho Nacional de Desenvolvimento Científico e Tecnológico | pt_BR |
dc.format.extent | 1037469 | pt_BR |
dc.language.iso | English | pt_BR |
dc.relation.ispartof | Frontiers in Microbiology | pt_BR |
dc.rights | Open access | pt_BR |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | pt_BR |
dc.title | Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity | pt_BR |
dc.type | Article | pt_BR |
dc.rights.license | CC BY | pt_BR |
dc.identifier.doi | 10.3389/fmicb.2022.1037469 | pt_BR |
dc.contributor.external | (UNICSUL) Universidade Cruzeiro do Sul | pt_BR |
dc.contributor.external | (NYU) New York University | pt_BR |
dc.contributor.external | (UNICAMP) Universidade Estadual de Campinas | pt_BR |
dc.identifier.citationvolume | 13 | pt_BR |
dc.subject.keyword | SARS-COV-2 | pt_BR |
dc.subject.keyword | lymphocyte | pt_BR |
dc.subject.keyword | macrophage | pt_BR |
dc.subject.keyword | neutrophil | pt_BR |
dc.subject.keyword | insulin resistance | pt_BR |
dc.relation.ispartofabbreviated | Front Microbiol | pt_BR |
dc.identifier.citationabnt | v. 13, 1037469, nov. 2022 | pt_BR |
dc.identifier.citationvancouver | 2022 Nov; 13:1037469 | pt_BR |
dc.contributor.butantan | Curi, Rui|:Outros|:Centro Bioindustrial | pt_BR |
dc.sponsorship.butantan | (FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2018/09868–7 | pt_BR |
dc.sponsorship.butantan | (FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2018/07283–1 | pt_BR |
dc.sponsorship.butantan | (FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2021/00200–6 | pt_BR |
dc.sponsorship.butantan | (CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior¦¦ | pt_BR |
dc.sponsorship.butantan | (CNPq) Conselho Nacional de Desenvolvimento Científico e Tecnológico¦¦ | pt_BR |
dc.identifier.bvscc | BR78.1 | pt_BR |
dc.identifier.bvsdb | IBProd | pt_BR |
dc.description.dbindexed | Yes | pt_BR |
item.fulltext | Com Texto completo | - |
item.openairetype | Article | - |
item.languageiso639-1 | English | - |
item.grantfulltext | open | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.journal.journalissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.journal.journaleissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
Appears in Collections: | Artigos |
Files in This Item:
Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity.pdf
Description:
Size: 2.89 MB
Format: Adobe PDF
View/Open
Description:
Size: 2.89 MB
Format: Adobe PDF
View/Open
This item is licensed under a Creative Commons License